[ad_1]
A study conducted by Verily, Duke University, and Stanford University demonstrated the potential of wrist-worn devices in detecting heart failure risk.
In this study, walking behavior collected by Verily Study Watch was associated with different levels of heart failure (HF) risk in people who were asymptomatic or at risk of developing HF compared to healthy patients. It was shown that The researchers published an evaluation of the device they studied in the Journal of Cardiac Failure.
Verily’s previous publication validated a suite of 18 digital measurements for gait and gait status classification. Based on this, the latest study adopted walking measures. Many of them showed a significant association with the preclinical stage of heart failure. Measurements collected from real-world environments were also correlated with clinical tests and studies of physical function.
The analysis included more than 1,200 participants from the Project Baseline Health Survey (PBHS), which Verily launched in 2017. PBHS aimed to help researchers better understand health and disease. Her PBHS, a long-term longitudinal study, included participants from diverse backgrounds representing a wide range of health conditions.
Verily says the PBHS shows that participants with subclinical heart failure have lower gait rhythm and pace compared to healthy people or people at risk. This could be expanded upon in future studies to determine how individuals at risk for heart failure or clinical deterioration can be identified from actual walking behavior, said Dr. Francois Haddad, clinical professor of cardiovascular medicine at Stanford University. It is said that there is a sex.
“Looking to the future, longitudinal registries combined with new data collection methods will play an important role in generating evidence that is representative of broad populations,” said Verily’s Chief Medical and Scientific Officer. says Dr. Andrew Trister. “This study shows the potential for us to continually learn about patient health and use that knowledge for more precise treatment and management of disease.”
[ad_2]
Source link